Cargando…

Brain-Derived Neurotrophic Factor (BDNF) Val(66)Met Polymorphism Differentially Predicts Hippocampal Function in Medication-Free Patients with Schizophrenia

A Val(66)Met single nucleotide polymorphism (SNP) in the brain-derived neurotrophic factor (BDNF) gene impairs activity-dependent BDNF release in cultured hippocampal neurons and predicts impaired memory and exaggerated basal hippocampal activity in healthy humans. Several clinical genetic associati...

Descripción completa

Detalles Bibliográficos
Autores principales: Eisenberg, Daniel Paul, Ianni, Angela M., Wei, Shau-Ming, Kohn, Philip D., Kolachana, Bhaskar, Apud, José, Weinberger, Daniel R., Berman, Karen F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3628926/
https://www.ncbi.nlm.nih.gov/pubmed/23319002
http://dx.doi.org/10.1038/mp.2012.187
_version_ 1782266487967318016
author Eisenberg, Daniel Paul
Ianni, Angela M.
Wei, Shau-Ming
Kohn, Philip D.
Kolachana, Bhaskar
Apud, José
Weinberger, Daniel R.
Berman, Karen F.
author_facet Eisenberg, Daniel Paul
Ianni, Angela M.
Wei, Shau-Ming
Kohn, Philip D.
Kolachana, Bhaskar
Apud, José
Weinberger, Daniel R.
Berman, Karen F.
author_sort Eisenberg, Daniel Paul
collection PubMed
description A Val(66)Met single nucleotide polymorphism (SNP) in the brain-derived neurotrophic factor (BDNF) gene impairs activity-dependent BDNF release in cultured hippocampal neurons and predicts impaired memory and exaggerated basal hippocampal activity in healthy humans. Several clinical genetic association studies, along with multi-modal evidence for hippocampal dysfunction in schizophrenia indirectly suggest a relationship between schizophrenia and genetically-determined BDNF function in the hippocampus. To directly test this hypothesized relationship, we studied 47 medication-free patients with schizophrenia or schizoaffective disorder and 74 healthy comparison individuals with genotyping for the Val(66)Met SNP and [(15)O]H(2)O positron emission tomography (PET) to measure resting and working memory-related hippocampal regional cerebral blood flow (rCBF). In patients, harboring a Met allele was associated with significantly less hippocampal rCBF. This finding was opposite to the genotype effect seen in healthy participants, resulting in a significant diagnosis-by-genotype interaction. Exploratory analyses of interregional resting rCBF covariation revealed a specific and significant diagnosis-by-genotype interaction effect on hippocampal-prefrontal coupling. A diagnosis-by-genotype interaction was also found for working-memory related hippocampal rCBF change, which was uniquely attenuated in Met allele-carrying patients. Thus, both task-independent and task-dependent hippocampal neurophysiology accommodates a Met allelic background differently in patients with schizophrenia than in control subjects. Potentially consistent with the hypothesis that cellular sequelae of the BDNF Val(66)Met SNP interface with aspects of schizophrenic hippocampal and frontotemporal dysfunction, these results warrant future investigation to understand the contributions of unique patient trait or state variables to these robust interactions.
format Online
Article
Text
id pubmed-3628926
institution National Center for Biotechnology Information
language English
publishDate 2013
record_format MEDLINE/PubMed
spelling pubmed-36289262013-12-01 Brain-Derived Neurotrophic Factor (BDNF) Val(66)Met Polymorphism Differentially Predicts Hippocampal Function in Medication-Free Patients with Schizophrenia Eisenberg, Daniel Paul Ianni, Angela M. Wei, Shau-Ming Kohn, Philip D. Kolachana, Bhaskar Apud, José Weinberger, Daniel R. Berman, Karen F. Mol Psychiatry Article A Val(66)Met single nucleotide polymorphism (SNP) in the brain-derived neurotrophic factor (BDNF) gene impairs activity-dependent BDNF release in cultured hippocampal neurons and predicts impaired memory and exaggerated basal hippocampal activity in healthy humans. Several clinical genetic association studies, along with multi-modal evidence for hippocampal dysfunction in schizophrenia indirectly suggest a relationship between schizophrenia and genetically-determined BDNF function in the hippocampus. To directly test this hypothesized relationship, we studied 47 medication-free patients with schizophrenia or schizoaffective disorder and 74 healthy comparison individuals with genotyping for the Val(66)Met SNP and [(15)O]H(2)O positron emission tomography (PET) to measure resting and working memory-related hippocampal regional cerebral blood flow (rCBF). In patients, harboring a Met allele was associated with significantly less hippocampal rCBF. This finding was opposite to the genotype effect seen in healthy participants, resulting in a significant diagnosis-by-genotype interaction. Exploratory analyses of interregional resting rCBF covariation revealed a specific and significant diagnosis-by-genotype interaction effect on hippocampal-prefrontal coupling. A diagnosis-by-genotype interaction was also found for working-memory related hippocampal rCBF change, which was uniquely attenuated in Met allele-carrying patients. Thus, both task-independent and task-dependent hippocampal neurophysiology accommodates a Met allelic background differently in patients with schizophrenia than in control subjects. Potentially consistent with the hypothesis that cellular sequelae of the BDNF Val(66)Met SNP interface with aspects of schizophrenic hippocampal and frontotemporal dysfunction, these results warrant future investigation to understand the contributions of unique patient trait or state variables to these robust interactions. 2013-01-15 2013-06 /pmc/articles/PMC3628926/ /pubmed/23319002 http://dx.doi.org/10.1038/mp.2012.187 Text en Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Eisenberg, Daniel Paul
Ianni, Angela M.
Wei, Shau-Ming
Kohn, Philip D.
Kolachana, Bhaskar
Apud, José
Weinberger, Daniel R.
Berman, Karen F.
Brain-Derived Neurotrophic Factor (BDNF) Val(66)Met Polymorphism Differentially Predicts Hippocampal Function in Medication-Free Patients with Schizophrenia
title Brain-Derived Neurotrophic Factor (BDNF) Val(66)Met Polymorphism Differentially Predicts Hippocampal Function in Medication-Free Patients with Schizophrenia
title_full Brain-Derived Neurotrophic Factor (BDNF) Val(66)Met Polymorphism Differentially Predicts Hippocampal Function in Medication-Free Patients with Schizophrenia
title_fullStr Brain-Derived Neurotrophic Factor (BDNF) Val(66)Met Polymorphism Differentially Predicts Hippocampal Function in Medication-Free Patients with Schizophrenia
title_full_unstemmed Brain-Derived Neurotrophic Factor (BDNF) Val(66)Met Polymorphism Differentially Predicts Hippocampal Function in Medication-Free Patients with Schizophrenia
title_short Brain-Derived Neurotrophic Factor (BDNF) Val(66)Met Polymorphism Differentially Predicts Hippocampal Function in Medication-Free Patients with Schizophrenia
title_sort brain-derived neurotrophic factor (bdnf) val(66)met polymorphism differentially predicts hippocampal function in medication-free patients with schizophrenia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3628926/
https://www.ncbi.nlm.nih.gov/pubmed/23319002
http://dx.doi.org/10.1038/mp.2012.187
work_keys_str_mv AT eisenbergdanielpaul brainderivedneurotrophicfactorbdnfval66metpolymorphismdifferentiallypredictshippocampalfunctioninmedicationfreepatientswithschizophrenia
AT ianniangelam brainderivedneurotrophicfactorbdnfval66metpolymorphismdifferentiallypredictshippocampalfunctioninmedicationfreepatientswithschizophrenia
AT weishauming brainderivedneurotrophicfactorbdnfval66metpolymorphismdifferentiallypredictshippocampalfunctioninmedicationfreepatientswithschizophrenia
AT kohnphilipd brainderivedneurotrophicfactorbdnfval66metpolymorphismdifferentiallypredictshippocampalfunctioninmedicationfreepatientswithschizophrenia
AT kolachanabhaskar brainderivedneurotrophicfactorbdnfval66metpolymorphismdifferentiallypredictshippocampalfunctioninmedicationfreepatientswithschizophrenia
AT apudjose brainderivedneurotrophicfactorbdnfval66metpolymorphismdifferentiallypredictshippocampalfunctioninmedicationfreepatientswithschizophrenia
AT weinbergerdanielr brainderivedneurotrophicfactorbdnfval66metpolymorphismdifferentiallypredictshippocampalfunctioninmedicationfreepatientswithschizophrenia
AT bermankarenf brainderivedneurotrophicfactorbdnfval66metpolymorphismdifferentiallypredictshippocampalfunctioninmedicationfreepatientswithschizophrenia